Next Generation Sequencing (NGS) Informatics Market (2023-2030)

The demand for sequencing data analysis tools has increased due to the rising research on novel molecules, growing genomic research projects, and the need for a single informatics platform to query and analyze data at multiple scales. NGS data analysis has been widely adopted in clinical and research settings, driven by the emerging needs in precision medicine research and the demand for consolidating and validating data.

NGS software is also adopted for a variety of pharmaceutical applications, such as processing massive volumes of raw sequence information/data into reliable and high-quality data. This allows researchers to store large-scale data, including data processing and sharing for multi-omics, phenotypic, genomics, and other biomedical data. The NGS informatics platforms have also shown promising results for global collaboration within or across organizations for data exchange while ensuring privacy and security standards.

The growth of the NGS informatics market is driven by increasing R&D investments by pharmaceutical and biotechnology companies, the growing utilization of NGS in disease diagnostics and precision medicine, technological advancements in NGS analysis software, and government initiatives supporting large-scale genomic sequencing projects. However, data confidentiality concerns restrain the growth of this market.

The increasing adoption of NGS informatics tools among hospitals and clinical laboratories and the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation are expected to create growth opportunities for the players operating in the NGS informatics market. However, the lack of skilled professionals required to operate NGS informatics tools is a major challenge for market growth.

NGS is widely used for cancer testing and is available in many diagnostic laboratories. Apart from cancer, NGS technologies are also increasingly utilized to diagnose several diseases. NGS can be used to diagnose a wide range of chronic diseases, from novel microbial agents that cause epidemics to heterogeneous mutations that cause complex inherited disorders. NGS is the best option for diagnosing complex diseases involving multiple genes. Autism, connective tissue disorders, cardiomyopathies, and disorders of sex development are a few such diseases. The traditional methods for detecting infectious diseases are time-consuming and sometimes require microbiological cultures. NGS, in contrast, can detect microorganisms directly from samples, including blood and cerebrospinal fluid (CSF).

NGS can effectively identify unculturable pathogens that routine culture and sensitivity assays cannot. Furthermore, NGS can also be used to identify pathogens in the early stages of a disease outbreak through genomic sequencing information. The causative factor for drug resistance can also be detected using whole genome sequencing. For instance, mecC is the causative factor for drug resistance in S. aureus infection, and ampC is the causative factor for drug resistance in E. coli infection.

NGS technology has gained significant traction in cancer treatment due to its speed, accuracy, and increasing affordability. It has played a crucial role in developing precision medicine, which involves customizing treatments based on specific molecular changes in a patient's body contributing to the disease. In oncology, NGS is utilized to sequence biopsy samples and identify genetic abnormalities responsible for tumor growth, enabling oncologists to select appropriate targeted therapies. These factors are expected to drive the NGS informatics market, as it becomes essential for managing the vast amount of data associated with disease diagnosis and treatment.

The advent of NGS has accelerated biological and medical research and discovery, allowing biologists and medical scientists to collect massive amounts of DNA sequence data rapidly and cost-effectively. In the past few years, the availability of advanced NGS technologies has lowered sequencing costs and significantly reduced the time required for DNA sequencing. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome decreased from $29,092 in 2010 to $562 in 2021, significantly increasing the adoption of NGS.

The huge volumes of data generated from NGS have created enormous pressure on healthcare providers in terms of data analysis, interpretation, reporting, and management. Sequening software has made it easier to create long sequencing runs, analyze sequencing data, monitor run status, and view results within shorter timeframes. Additionally, data flow from instruments can now be processed by software, making it easier to manage and analyze data using analysis applications.

Sequencing data analysis solutions offer additional features, such as data security and accuracy, by converting sequencing information into a standard format. This allows for the monitoring of instrument run quality and the streaming of data directly to on-premise or cloud servers. Also, benefits such as access to computing resources with minimum in-house infrastructure and increased efficiency with easy access to a multitude of genomic analysis applications have significantly increased the adoption of NGS informatics solutions.